Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 308 $ 201,813 $ (112,143) $ 265 $ (6,053) $ (10) $ 84,180
Balance, shares at Dec. 31, 2019 30,804            
Net loss attributable to common stockholders (1,123) (3,426) (4,549)
Foreign currency translation adjustment (2,326) (20) (2,346)
Issuance of restricted shares
Issuance of restricted shares, shares 40            
Forfeiture of restricted shares
Forfeiture of restricted shares, shares (32)            
Vesting of restricted stock units $ 1 (1)
Vesting of restricted stock units, shares 110            
Shares issued pursuant to exercise of stock options $ 1 $ 382 $ 383
Shares issued pursuant to exercise of stock options, shares 90            
Shares withheld pursuant to vesting of restricted stock (232) (232)
Other   $ 62 $ 62
Net loss attributable to non-controlling interest (15) (15)
Shares withheld pursuant to exercise of stock options (256) (256)
Stock based compensation 1,155 1,155
Ending balance, value at Mar. 31, 2020 $ 310 202,288 (115,569) (2,061) (6,541) (45) 78,382
Balance, shares at Mar. 31, 2020 31,012            
Beginning balance, value at Dec. 31, 2019 $ 308 201,813 (112,143) 265 (6,053) (10) 84,180
Balance, shares at Dec. 31, 2019 30,804            
Net loss attributable to common stockholders             (8,315)
Net loss attributable to non-controlling interest             (16)
Ending balance, value at Jun. 30, 2020 $ 322 206,405 (118,195) (1,655) (6,557) (44) 80,276
Balance, shares at Jun. 30, 2020 32,153            
Beginning balance, value at Mar. 31, 2020 $ 310 202,288 (115,569) (2,061) (6,541) (45) 78,382
Balance, shares at Mar. 31, 2020 31,012            
Net loss attributable to common stockholders (1,140) (2,626) (3,766)
Foreign currency translation adjustment 406 2 408
Issuance of restricted shares $ 3 (3)
Issuance of restricted shares, shares 276            
Forfeiture of restricted shares
Forfeiture of restricted shares, shares (12)            
Vesting of restricted stock units
Vesting of restricted stock units, shares 17            
Shares issued pursuant to exercise of stock options $ 1 $ 215 $ 216
Shares issued pursuant to exercise of stock options, shares 50            
Shares withheld pursuant to vesting of restricted stock (16) (16)
Net loss attributable to non-controlling interest $ (1) $ (1)
Common shares issued under the 2020 ATM $ 8 4,033 4,041
Common shares issued under the 2020 ATM, shares 810            
Stock based compensation 1,012 1,012
Ending balance, value at Jun. 30, 2020 $ 322 206,405 (118,195) (1,655) (6,557) (44) 80,276
Balance, shares at Jun. 30, 2020 32,153            
Beginning balance, value at Dec. 31, 2020 $ 323 206,499 (121,150) 399 (6,858) 75 79,288
Balance, shares at Dec. 31, 2020 32,280            
Net loss attributable to common stockholders (1,196) (1,787) (2,983)
Foreign currency translation adjustment (1,334) (2) (1,336)
Issuance of restricted shares $ 4 (4)
Issuance of restricted shares, shares 415            
Forfeiture of restricted shares
Forfeiture of restricted shares, shares (6)            
Vesting of restricted stock units  
Vesting of restricted stock units, shares 34            
Shares issued pursuant to exercise of stock options $ 1 $ 716 $ 717
Shares issued pursuant to exercise of stock options, shares 129            
Shares withheld pursuant to vesting of restricted stock (347) (347)
Shares withheld pursuant to exercise of stock options $ (647) $ (647)
Stock based compensation 1,357 1,357
Common shares issued, net of issuance costs $ 44 26,822 26,866
Common shares issued, net of issuance costs, shares 4,428            
Ending balance, value at Mar. 31, 2021 $ 372 234,194 (122,937) (935) (7,852) 73 102,915
Balance, shares at Mar. 31, 2021 37,280            
Beginning balance, value at Dec. 31, 2020 $ 323 206,499 (121,150) 399 (6,858) 75 79,288
Balance, shares at Dec. 31, 2020 32,280            
Net loss attributable to common stockholders             (5,616)
Net loss attributable to non-controlling interest             (1)
Ending balance, value at Jun. 30, 2021 $ 373 234,165 (124,375) 68 (7,867) 79 102,443
Balance, shares at Jun. 30, 2021 37,278            
Beginning balance, value at Mar. 31, 2021 $ 372 234,194 (122,937) (935) (7,852) 73 102,915
Balance, shares at Mar. 31, 2021 37,280            
Net loss attributable to common stockholders (1,195) (1,438) (2,633)
Foreign currency translation adjustment 1,003 7 1,010
Forfeiture of restricted shares
Forfeiture of restricted shares, shares (14)            
Vesting of restricted stock units  
Vesting of restricted stock units, shares            
Shares issued pursuant to exercise of stock options $ 1 $ 71 $ 72
Shares issued pursuant to exercise of stock options, shares 12            
Shares withheld pursuant to vesting of restricted stock (15) (15)
Net loss attributable to non-controlling interest $ (1) $ (1)
Stock based compensation 1,095 1,095
Ending balance, value at Jun. 30, 2021 $ 373 $ 234,165 $ (124,375) $ 68 $ (7,867) $ 79 $ 102,443
Balance, shares at Jun. 30, 2021 37,278